Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.

Thrombosis research - 1 Sept 2009

Heylen Evelien, Miljic Predrag, Willemse Johan, Djordjevic Valentina, Radojkovic Dragica, Colovic Milica, Elezovic Ivo, Hendriks Dirk

Abstract excerpt

INTRODUCTION: It is considered that high plasma levels of procarboxypeptidase U (proCPU or TAFI) can promote the development of thrombosis, but data comparing proCPU levels in thrombophilia carriers and healthy subjects are rather scarce. Moreover, the results of previous studies on the risk of thrombosis related to high proCPU concentration in this population were not consistent. Although the 325 polymorphism of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prothrombin
Share to Thrombophilia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carboxypeptidase B2

Share to Genetic Predisposition to Disease

Share to Mutation

Share to Polymorphism, Genetic

Share to Thrombosis

Source

Identifiers

PMID: 19195685
DOI: 10.1016/j.thromres.2009.01.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.PMID 19195685Read ↗

Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?Semantic proximity Read ↗

Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages.Semantic proximity Read ↗

Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.Semantic proximity Read ↗

The 536C→T Transition in the Human Tissue Factor Pathway Inhibitor (TFPI) Gene Is Statistically Associated with a Higher Risk for Venous ThrombosisSemantic proximity Read ↗

Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.Semantic proximity Read ↗

The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).Semantic proximity Read ↗

Familial thrombotic risk based on the genetic background of Protein C Deficiency in a Portuguese Study.Semantic proximity Read ↗

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels.Semantic proximity Read ↗

Polymorphisms in the TAFI gene and the risk of venous thrombosis.Semantic proximity Read ↗

Genotype-Phenotype Relationships in a Large French Cohort of Subjects with Inherited Protein C Deficiency.Semantic proximity Read ↗

Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family.Semantic proximity Read ↗

Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.